Research Article
Open Access
Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade
View ORCID ProfileYuki Miyai, Daisuke Sugiyama, View ORCID ProfileTetsunari Hase, Naoya Asai, Tetsuro Taki, View ORCID ProfileKazuki Nishida, Takayuki Fukui, Toyofumi Fengshi Chen-Yoshikawa, View ORCID ProfileHiroki Kobayashi, Shinji Mii, View ORCID ProfileYukihiro Shiraki, Yoshinori Hasegawa, View ORCID ProfileHiroyoshi Nishikawa, Yuichi Ando, Masahide Takahashi, View ORCID ProfileAtsushi Enomoto Correspondence email
Yuki Miyai
1Department of Pathology, Nagoya University Hospital, Nagoya, Japan
2Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan
Roles: Conceptualization, Data curation, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing—original draft, review, and editing
Daisuke Sugiyama
3Department of Immunology, Nagoya University Hospital, Nagoya, Japan
Roles: Data curation, Formal analysis, Methodology
Tetsunari Hase
4Department of Respiratory Medicine, Nagoya University Hospital, Nagoya, Japan
Roles: Resources
Naoya Asai
1Department of Pathology, Nagoya University Hospital, Nagoya, Japan
Roles: Resources
Tetsuro Taki
1Department of Pathology, Nagoya University Hospital, Nagoya, Japan
Roles: Resources, Investigation
Kazuki Nishida
5Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan
Roles: Formal analysis
Takayuki Fukui
6Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
Roles: Resources
Toyofumi Fengshi Chen-Yoshikawa
6Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
Roles: Resources
Hiroki Kobayashi
1Department of Pathology, Nagoya University Hospital, Nagoya, Japan
Roles: Resources
Shinji Mii
1Department of Pathology, Nagoya University Hospital, Nagoya, Japan
Roles: Resources, Investigation, Writing—review and editing
Yukihiro Shiraki
1Department of Pathology, Nagoya University Hospital, Nagoya, Japan
Roles: Resources, Investigation
Yoshinori Hasegawa
4Department of Respiratory Medicine, Nagoya University Hospital, Nagoya, Japan
Roles: Resources
Hiroyoshi Nishikawa
3Department of Immunology, Nagoya University Hospital, Nagoya, Japan
7Division of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Tokyo, Japan
Roles: Resources, Supervision
Yuichi Ando
2Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan
Roles: Resources, Supervision, Funding acquisition
Masahide Takahashi
1Department of Pathology, Nagoya University Hospital, Nagoya, Japan
Roles: Resources, Supervision, Funding acquisition
Atsushi Enomoto
1Department of Pathology, Nagoya University Hospital, Nagoya, Japan
Roles: Supervision, Funding acquisition, Project administration, Writing—original draft, review, and editing
Published 2 March 2022. DOI: 10.26508/lsa.202101230
Meflin+ CAFs enhance response to ICB
Yuki Miyai, Daisuke Sugiyama, Tetsunari Hase, Naoya Asai, Tetsuro Taki, Kazuki Nishida, Takayuki Fukui, Toyofumi Fengshi Chen-Yoshikawa, Hiroki Kobayashi, Shinji Mii, Yukihiro Shiraki, Yoshinori Hasegawa, Hiroyoshi Nishikawa, Yuichi Ando, Masahide Takahashi, Atsushi Enomoto
Life Science Alliance Mar 2022, 5 (6) e202101230; DOI: 10.26508/lsa.202101230
Meflin+ CAFs enhance response to ICB
Yuki Miyai, Daisuke Sugiyama, Tetsunari Hase, Naoya Asai, Tetsuro Taki, Kazuki Nishida, Takayuki Fukui, Toyofumi Fengshi Chen-Yoshikawa, Hiroki Kobayashi, Shinji Mii, Yukihiro Shiraki, Yoshinori Hasegawa, Hiroyoshi Nishikawa, Yuichi Ando, Masahide Takahashi, Atsushi Enomoto
Life Science Alliance Mar 2022, 5 (6) e202101230; DOI: 10.26508/lsa.202101230
In this Issue
Volume 5, No. 6
June 2022
Advertisement
Jump to section
Subjects
Related Articles
- No related articles found.
Cited By...
- No citing articles found.